References
- PiatkovIRochesterCJonesTBoyagesSWarfarin toxicity and individual variability-clinical caseToxins20102112584259222069565
- JohnsonJAGongLWhirl-CarrilloMClinical Pharmacogenetics Implementation ConsortiumClinical pharmacogenetics implementation consortium guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosingClin Pharmacol Ther201190462562921900891
- PirmohamedMKamaliFDalyAKWadeliusMOral anticoagulation a critique of recent advances and controversiesTrends Pharmacol Sci201536315316325698605
- FangMCGoASChangYDeath and disability from warfarin-associated intracranial hemorrhagesAm J Med2007120870070517679129
- Penning-van BeestFJAvan MeegenERosendaalFRStrickerBHCharacteristics of anticoagulation therapy and comorbidity related to overanticoagulationThromb Haemost200186256957411522005
- WittkowskyAKFactors associated with INR elevation and bleeding complications during warfarin therapyArch Intern Med2005165670315795354
- ZhouLWangSZhangZPharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirinJ Ethnopharmacol2012143264865522867637
- GaoLCHuangXTanZRFanLZhouHHThe effects of sodium ferulate on the pharmacokinetics of bupropion and its active metabolite in healthy menEur Rev Med Pharmacol Sci20121691192119623047502
- MelnikGSchwesingerWHTengRDogoloLCVincentJHepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteersEur J Clin Microbiol Infect Dis19981764244269758286
- LenzenRBahrAEichstadtHMarschallUBechsteinWONeuhausPIn liver transplantation T tube bile represents total bile flow physiological and scintigraphic studies on biliary secretion of organic anionsLiver Transpl Surg1999518159873086
- BaroneECalabreseVMancusoCFerulic acid and its therapeutic potential as a hormetin for age-related diseasesBiogerontology20091029710818651237
- D’ArchivioMFilesiCDi BenedettoRGargiuloRGiovanniniCMasellaRPolyphenols dietary sources and bioavailabilityAnn Ist Super Sanita200743434836118209268
- ShiXTangYZhuHPharmacokinetic comparison of seven major bio-active components in normal and blood deficiency rats after oral administration of Danggui Buxue decoction by UPLC-TQ/MSJ Ethnopharmacol2014153116917724583239
- LiJMZhaoYHZhongGCLongZJZhouPYuanMSynthesis of ferulic acid derivatives and their inhibitory effect on platelet aggregationYao Xue Xue Bao201146330531021626785
- WangSGaoZChenXThe anticoagulant ability of ferulic acid and its applications for improving the blood compatibility of silk fibroinBiomed Mater20083404410619029605
- SuzukiAYamamotoMJokuraHFerulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive ratsAm J Hypertens200720550851317485012
- WuWWYeungJHInhibition of warfarin hydroxylation by major tanshinones of Danshen (Salvia miltiorrhiza) in the rat in vitro and in vivoPhytomedicine2010173–421922619577456
- ShaoJJiaLPotential serious interactions between nutraceutical ginseng and warfarin in patients with ischemic strokeTrends Pharmacol Sci2013342858623277336
- RobertsMSMagnussonBMBurczynskiFJWeissMEnterohepatic circulation physiological pharmacokinetic and clinical implicationsClin Pharmacokinet2002411075179012162761
- WadeliusMChenLYLindhJDThe largest prospective warfarin-treated cohort supports genetic forecastingBlood2009113478479218574025
- BodinLVerstuyftCTregouetDACytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivityBlood2005106113514015790782
- LimMKSadaranganiPChanHLHengJYComplementary and alternative medicine use in multiracial SingaporeComplement Ther Med2005131162415907674
- CuzzolinLFrancini-PesentiFZaffaniSKnowledges about herbal products among subjects on warfarin therapy and patient-physician relationship a pilot studyPharmacoepidemiol Drug Saf20071691014101717615601
- WongRSChengGChanTYUse of herbal medicines by patients receiving warfarinDrug Saf200326858558812825970
- WangBHOu-YangJPPharmacological actions of sodium ferulate in cardiovascular systemCardiovasc Drug Rev200523216117216007232
- ZhangEShenFBlood compatibility of a ferulic acid (FA)-eluting PHBHHx system for biodegradable magnesium stent applicationMater Sci Eng C Mater Biol Appl201552374525953538
- WangHZhangYXiaTSynergistic promotion of blood vessel regeneration by Astragaloside IV and ferulic acid from electrospun fibrous matsMol Pharm20131062394240323651405
- ZhaoZMoghadasianMHChemistry natural sources dietary intake and pharmacokinetic properties of ferulic acid: a reviewFood Chem2008109469170226049981
- PoquetLCliffordMNWilliamsonGTransport and metabolism of ferulic acid through the colonic epitheliumDrug Metab Dispos200836119019717954526
- ZhaoZEgashiraYSanadaHFerulic acid is quickly absorbed from rat stomach as the free form and then conjugated mainly in liverJ Nutr2004134113083308815514279